Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box

Toxoplasma gondii is a cosmopolitan protozoan parasite which affects approximately 30% of the population worldwide. The drugs currently used against toxoplasmosis are few in number and show several limitations, such as drug intolerance, poor bioavailability, or drug resistance mechanism developed by...

Descripción completa

Detalles Bibliográficos
Autores principales: Spalenka, Jérémy, Escotte-Binet, Sandie, Bakiri, Ali, Hubert, Jane, Renault, Jean-Hugues, Velard, Frédéric, Duchateau, Simon, Aubert, Dominique, Huguenin, Antoine, Villena, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786798/
https://www.ncbi.nlm.nih.gov/pubmed/29133550
http://dx.doi.org/10.1128/AAC.01640-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786798/
https://www.ncbi.nlm.nih.gov/pubmed/29133550
http://dx.doi.org/10.1128/AAC.01640-17

Ejemplares similares